SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011410
Filing Date
2018-08-10
Accepted
2018-08-10 17:22:22
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 804066
2 ex31-1.htm EX-31.1 17522
3 ex31-2.htm EX-31.2 17583
4 ex32-1.htm EX-32.1 6113
5 ex32-2.htm EX-32.2 6135
  Complete submission text file 0001493152-18-011410.txt   3883134

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mrna-20180630.xml EX-101.INS 501382
7 XBRL SCHEMA FILE mrna-20180630.xsd EX-101.SCH 44065
8 XBRL CALCULATION FILE mrna-20180630_cal.xml EX-101.CAL 45593
9 XBRL DEFINITION FILE mrna-20180630_def.xml EX-101.DEF 238445
10 XBRL LABEL FILE mrna-20180630_lab.xml EX-101.LAB 331132
11 XBRL PRESENTATION FILE mrna-20180630_pre.xml EX-101.PRE 282550
Mailing Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748
Business Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 181009766
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1